Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9993543
Immunogenic compositions comprising silicified virus and methods of use
granted -
US 9993537
Methods and compositions related to Th-1 dendritic cells
granted -
US 9993461
Method for treating disorders associated with glomerular function
granted -
US 9993501
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9993481
Methods and compositions for the treatment of metabolic disorders
granted -
US 9993449
(S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and related compounds as GABA aminotransferase inactivators for the treatment of epilepsy, addiction and hepatocellular carcinoma
granted -
US 9993450
Dosage forms and therapeutic uses of L-4-chlorokynurenine
granted -
US 9993437
Mesoporous silica nanoparticles for biomedical applications
granted -
US 9993394
Dental restorative composition
granted -
US 9994910
Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
granted -
US 9994860
Regulating alkaloids
granted -
US 9994855
Compositions and methods for modulating growth hormone receptor expression
granted -
US 9994847
miR-29 mimics and uses thereof
granted -
US 9994817
Use of ligands for the programmed cell death receptor conjugated to solid supports for cultivating human regulatory T cells
granted -
US 9993453
Dosage forms and therapeutic uses L-4-chlorokynurenine
granted -
US 9994814
Method for cellular restoration
granted -
US 9993440
Enzyme responsive nanocapsules for protein delivery
granted -
US 9994547
Heteroarylamide inhibitors of TBK1
granted -
US 9993545
Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
granted -
US 9993502
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9993510
Acne-removing traditional chinese medicine composition and preparation method thereof
granted -
US 9994617
Modulation of structured polypeptide specificity
granted -
US 9994901
Pro-inflammatory mediators in diagnosis and treatment of chronic obstructive pulmonary disease
granted -
US 9994613
Prodrug of an ICE inhibitor
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.